The economics of mental health
October 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HEOR, health economics and outcomes research, mental health, pharma
Louis Goss examines mental health from a health economics and outcomes research (HEOR) perspective and asks what might be done …
NICE recommends Pfizer’s Mylotarg combo in CD33-positive acute myeloid leukaemia
October 8, 2018Sales and Marketing Mylotarg, NICE, Pfizer, acute myeloid leukaemia, leukaemia, pharma
NICE has revealed its recommendation for Pfizer’s Mylotarg (gemtuzumab ozogamicin) to be used on the NHS in the treatment of …
NIHR whitepaper claims UK needs High Throughput Centres after Brexit
October 8, 2018Sales and Marketing NHS, NIHR, UK, clinical trials, phase III
The National Institute for Health Research (NIHR) has released a new whitepaper outlining the substantial benefits NHS High Throughput Centres …
Tech firm Tencent aims for 3-minute Alzheimer’s diagnosis with new partnership
October 8, 2018Research and Development, Sales and Marketing Alzheimer's, pharma, tencent
Chinese tech firm Tencent has partnered up with London-based healthcare technology firm Medopad in a big to accelerate the diagnosis …
US FDA approves HPV vaccine for men and women aged 27-45
October 8, 2018Sales and Marketing CDC, Cancer, FDA, HPV, approval, infectious diseases, vaccines
The US Food and Drug Administration have approved the use of HPV vaccine Gardasil 9 for both men and woman …
MSD signs $117m deal with Samsung Bioepis over Janssen biosimilar
October 8, 2018Sales and Marketing Biogen, Janssen, MSD, Samsung, Samsung Bioepis
American multinational MSD have won a $117 million contract allowing them to supply Samsung Bioepis’ Renflexis to the US Department …
GSK to cut almost 200 jobs at UK site
October 5, 2018Manufacturing and Production, Medical Communications GSK, UK, Ulverston, job cuts, pharma
GlaxoSmithKline has announced that it is to slash half of its workforce at its site in Ulverston, UK, as part …
Top Ten most popular articles on Pharmafile.com this week
October 5, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Jannsen, NHS, Novartis, Novo Nordisk, dementia, top 10
As September came to a close and October began the UK was hit hard in the headlines after American firm …
FDA expands indication of Roche’s Hemlibra in haemophilia
October 5, 2018Medical Communications, Sales and Marketing Hemlibra, Roche, haemophilia, pharma
The FDA has chosen to expand the label of Roche’s Hemlibra (emicizumab-kxwh), approving it for routine prophylaxis to prevent the …
NHS England appoves Gilead’s CAR T therapy Yescarta
October 5, 2018Medical Communications Gilead, NHS, NICE, UK, Yescarta
Gilead’s CAR T therapy Yescarta is set to be made available on the NHS in England for adults with aggressive …
MHRA to consult on potential for no-deal Brexit
October 5, 2018Medical Communications EU, MHRA, brexit, uk politics
The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would …
Ian Read steps down as Pfizer CEO
October 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Ian Read, Pfizer, pharma
Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …
The value of measuring biotech Board performance
October 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing RSA Group, biotech, board, life sciences, opinion, pharma
Nick Stephens of The RSA Group discusses the importance of stopping to quantify the effectiveness of board members within life …
Roche’s flu drug speeds up recovery in Phase III trial
October 4, 2018Research and Development Roche, drug, flu, pharma, recovery
Swiss multinational Roche’s flu drug baloxavir marboxil significantly sped up recovery time in comparison with placebo, in people at high …
Bayer to cut 227 positions in California to drive efficiency in haemophilia
October 4, 2018Manufacturing and Production Bayer, haemophilia, pharma
Bayer has announced its intention to axe 227 employees at a manufacturing site in California as part of a push …
New group blames PBM’s and hospitals for rising drug prices
October 4, 2018Medical Communications, Sales and Marketing Alliance to Protect Medical Innovation, Drug pricing, PhRMA, Trunmp, aha, pharma
A new group, organised under the banner of the Alliance to Protect Medical Innovation, is blaming hospitals and PBM’s for …
Baxter partners up with Mayo Clinic for new “centre of exellence” in renal care
October 4, 2018Research and Development Mayo Clinic, baxter, kidney disease, pharma, renal
American pharma firm Baxter has announced a new partnership with the Mayo Clinic in a bid to establish a “renal …
Survey reveals 56% gender pay gap between doctors in NHS
October 4, 2018Medical Communications NHS, UK, brexit, doctors, pay gap
Male doctors in the United Kingdom earn 56% more than their female counterparts, according to a survey conducted by Medscape. …
Lilly’s Verzenio gets first-line EU approval for HER2- advanced breast cancer
October 3, 2018Research and Development, Sales and Marketing Cancer, Eli Lilly, Verzenio, breast cancer, pharma
The European Medicines Agency has confirmed its approval of Eli Lilly’s CDK4/6 inhibitor Verzenio (ademaciclib), it has emerged. The therapy …
FDA cracks down on e-cig maker Juul in surprise inspection
October 3, 2018Research and Development FDA, e-cig, juul, surprise inspection, us San Francisco
The US FDA have launched a surprise inspection of e-cigarette maker Juul’s corporate headquarters in San Francisco, having seized thousands …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
